Time Horizon |
30 years |
Annual discount rate |
3% |
Annual transition probabilities |
|
Disease onset (healthy to S1) |
0.15 |
Recovery (S1 to healthy) |
0.5 |
Disease progression (S1 to S2) |
(0.01 – 0.48) |
Annual probability of death |
|
Healthy individuals |
0.005 |
Relative risk in S1, relative to healthy |
(1.0 – 4.5) |
Relative risk in S2, relative to healthy |
(1.0 – 20) |
Annual costs |
|
Healthy individuals |
$2,000 |
Sick individuals in S1 |
$4,000 |
Sick individuals in S2 |
$15,000 |
Quality-of-life |
|
Healthy individuals |
1.00 |
Sick individuals in S1 |
0.75 |
Sick individuals in S2 |
0.50 |
Intervention effects |
|
Annual treatment cost per sick individual |
$12,000 |
Quality-of-life of treated individuals in S1 |
0.95 |
|
Calibration Target |
Target Value |
|
Overall 5-year survival |
98% |
Overall 10-year survival |
84% |
Prevalence of disease in year 5 |
15% |
Ratio of S1:S2 |
8:1 |